Literature DB >> 18802041

Phenotypic and functional reversal within the early human hematopoietic compartment.

Shoshan Knaän-Shanzer1, Ietje van der Velde-van Dijke, Marloes J M van de Watering, Philip J de Leeuw, Dinko Valerio, Dirk W van Bekkum, Antoine A F de Vries.   

Abstract

The fate of phenotypically defined human hematopoietic stem cells (hHSCs) in culture and the link between their surface marker expression profile and function are still controversial. We studied these aspects of hHSC biology by relating the expression of the early lineage markers (ELM) CD33, CD38, and CD71 on the surface of human umbilical cord blood (UCB) CD34(+) cells to their long-term nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse repopulation activity (LT-SRA). In uncultured UCB samples, LT-SRA was largely confined to the small CD34(+)ELM(-) cell fraction. CD34(+) cells expressing ELM markers at their surface usually lacked LT-SRA. After culturing UCB CD34(+) cells for 6 days in serum-free medium and on a feeder layer of Rat2 cells, the number of CD34(+)ELM(-) cells stayed roughly the same or showed a slight increase and the LT-SRA was preserved, suggesting a close association between LT-SRA and the CD34(+)ELM(-) phenotype. Indeed, transplantation of CD34(+)ELM(-) cells isolated from cultured UCB CD34(+) cells resulted in long-term hematopoietic reconstitution of conditioned NOD/SCID mice, whereas CD34(+)ELM(+) cells derived from the same cultures were devoid of LT-SRA. Remarkably, roughly 1% of the cells recovered from cultures initiated with isolated CD34(+)ELM(+) cells had lost ELM surface expression. Concurrently, the cultured CD34(+)ELM(+) cells acquired LT-SRA, suggesting that hematopoietic stem cells (HSCs) may arise by the dedifferentiation of early hematopoietic progenitor cells. The latter finding challenges the paradigm of unidirectional hematopoietic differentiation and opens new opportunities for HSC expansion prior to transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802041     DOI: 10.1634/stemcells.2007-0117

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  9 in total

Review 1.  To breathe or not to breathe: the haematopoietic stem/progenitor cells dilemma.

Authors:  C Piccoli; F Agriesti; R Scrima; F Falzetti; M Di Ianni; N Capitanio
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

2.  Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.

Authors:  Lai Sum Leoh; Yoon Kyung Kim; Pierre V Candelaria; Otoniel Martínez-Maza; Tracy R Daniels-Wells; Manuel L Penichet
Journal:  J Immunol       Date:  2018-04-13       Impact factor: 5.422

3.  Ex vivo expansion and long-term hematopoietic reconstitution ability of sorted CD34+CD59+ cells from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Juan Xiao; Bing Han; Yong-Ji Wu; Yu-ping Zhong; Wan-ling Sun
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

4.  Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.

Authors:  Anabel S de la Garza-Rodea; Marieke C Verweij; Hester Boersma; Ietje van der Velde-van Dijke; Antoine A F de Vries; Rob C Hoeben; Dirk W van Bekkum; Emmanuel J H J Wiertz; Shoshan Knaän-Shanzer
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

5.  Generation of hematopoietic humanized mice in the newborn BALB/c-Rag2null Il2rγnull mouse model: a multivariable optimization approach.

Authors:  Julie Lang; Nicholas Weiss; Brian M Freed; Raul M Torres; Roberta Pelanda
Journal:  Clin Immunol       Date:  2011-04-14       Impact factor: 3.969

Review 6.  Iron in multiple myeloma.

Authors:  Kristina VanderWall; Tracy R Daniels-Wells; Manuel Penichet; Alan Lichtenstein
Journal:  Crit Rev Oncog       Date:  2013

7.  Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.

Authors:  Tracy R Daniels-Wells; Gustavo Helguera; José A Rodríguez; Lai Sum Leoh; Michael A Erb; Graciel Diamante; David Casero; Matteo Pellegrini; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  Toxicol In Vitro       Date:  2012-10-17       Impact factor: 3.500

Review 8.  Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.

Authors:  Pierre V Candelaria; Lai Sum Leoh; Manuel L Penichet; Tracy R Daniels-Wells
Journal:  Front Immunol       Date:  2021-03-17       Impact factor: 7.561

9.  Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections.

Authors:  Brady T Hickerson; Tracy R Daniels-Wells; Cristian Payes; Lars E Clark; Pierre V Candelaria; Kevin W Bailey; Eric J Sefing; Samantha Zink; James Ziegenbein; Jonathan Abraham; Gustavo Helguera; Manuel L Penichet; Brian B Gowen
Journal:  Nat Commun       Date:  2022-01-28       Impact factor: 17.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.